The new definition and diagnostic criteria of Parkinson's disease

The Lancet Neurology

Volumn 15, Issue 6, 2016, Pages 546-548

  Postuma, Ronald B ^b   Berg, Daniela ^a   Adler, Charles H ^c   Bloem, Bastiaan R ^d   Chan, Piu ^e   Deuschl, Günther ^f   Gasser, Thomas ^a   Goetz, Christopher G ^g   Halliday, Glenda ^h   Joseph, Lawrence ⁱ   Lang, Anthony E ^j   Liepelt Scarfone, Inga ^a   Litvan, Irene ^k   Marek, Kenneth ^a,l   Oertel, Wolfgang ^m   Olanow, C Warren ⁿ   Poewe, Werner ^o   Stern, Matthew ^p  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c MAYO CLINIC   (United States)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f UNIVERSITY OF KIEL   (Germany)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF NEW SOUTH WALES   (Australia)

ⁱ MCGILL UNIVERSITY   (Canada)

^j TORONTO WESTERN HOSPITAL   (Canada)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l INSTITUTE FOR NEURODEGENERATIVE DISORDERS   (United States)

^m PHILIPPS UNIVERSITY MARBURG   (Germany)

ⁿ MOUNT SINAI HOSPITAL   (United States)

^o INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^p Penn Neurological Institute   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSE LEWY BODY DISEASE; DISEASE CLASSIFICATION; EVIDENCE BASED PRACTICE; HUMAN; LETTER; MOVEMENT DISORDER SOCIETY CRITERIA; NEUROLOGIC DISEASE ASSESSMENT; PARKINSON DISEASE; PARKINSONISM; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRODROMAL SYMPTOM; STAGING; STANDARDIZATION; SYNDROME DELINEATION;

HUMANS; PARKINSON DISEASE;

EID: 84962873324     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(16)00116-2     Document Type: Letter

References (4)

1. Building on 50 years of levodopa therapy. Lancet Neurol 2016, 15:1. The Lancet Neurology.
2. Postuma RB, Berg D, Stern M, et al. MDS Clinical Diagnostic Criteria for Parkinson's Disease. Mov Disord 2015, 30:1591-1601.
3. Berg D, Postuma RB, Adler CH, et al. MDS Research Criteria for Prodromal Parkinson's Disease. Mov Disord 2015, 30:1600-1611.
4. Berg D, Postuma RB, Bloem B, et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Mov Disord 2014, 29:454-462.